US Patent Issued to Xencor on Aug. 26 for "Heterodimeric antibodies that bind CD3 and CLDN6" (California, Minnesota Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,207, issued on Aug. 26, was assigned to Xencor Inc. (Pasadena, Calif.).

"Heterodimeric antibodies that bind CD3 and CLDN6" was invented by Matthew S. Faber (Glendora, Calif.), Sung-Hyung Lee (San Gabriel, Calif.), Yoon Kyung Kim (Pomona, Calif.), Jing Qi (Arcadia, Calif.), Kendra N. Avery (Hawthorne, Calif.), Seung Y. Chu (Upland, Calif.), Alex Nisthal (Monrovia, Calif.), Matthew J. Bernett (Monrovia, Calif.), John R. Desjarlais (Pasadena, Calif.) and Chad Borchert (Nowthen, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are novel CLDN6 binding domains, and anti-CLDN6xanti-CD3 antibodies that include such CLDN6 binding domains....